Correlation Between Cara Therapeutic and Kintara Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cara Therapeutic and Kintara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cara Therapeutic and Kintara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cara Therapeutic and Kintara Therapeutics, you can compare the effects of market volatilities on Cara Therapeutic and Kintara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cara Therapeutic with a short position of Kintara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cara Therapeutic and Kintara Therapeutics.

Diversification Opportunities for Cara Therapeutic and Kintara Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cara and Kintara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cara Therapeutic and Kintara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kintara Therapeutics and Cara Therapeutic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cara Therapeutic are associated (or correlated) with Kintara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kintara Therapeutics has no effect on the direction of Cara Therapeutic i.e., Cara Therapeutic and Kintara Therapeutics go up and down completely randomly.

Pair Corralation between Cara Therapeutic and Kintara Therapeutics

If you would invest (100.00) in Kintara Therapeutics on January 20, 2024 and sell it today you would earn a total of  100.00  from holding Kintara Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Cara Therapeutic  vs.  Kintara Therapeutics

 Performance 
       Timeline  
Cara Therapeutic 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cara Therapeutic are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Cara Therapeutic sustained solid returns over the last few months and may actually be approaching a breakup point.
Kintara Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kintara Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kintara Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Cara Therapeutic and Kintara Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cara Therapeutic and Kintara Therapeutics

The main advantage of trading using opposite Cara Therapeutic and Kintara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cara Therapeutic position performs unexpectedly, Kintara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kintara Therapeutics will offset losses from the drop in Kintara Therapeutics' long position.
The idea behind Cara Therapeutic and Kintara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stocks Directory
Find actively traded stocks across global markets